Real World Data in Stage III Melanoma in Latino Low Middle Income Country: Prognostic Factors and Outcomes
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.28047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Gabriel De La Cruz Ku und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Cientifica del Sur, Lima, Peru. Hauptthemen laut MEDLINE: Hispanic or Latino, Melanoma, Skin Neoplasms. Die Arbeit nennt 33 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
Malignant melanoma is a heterogeneous disease, with varying outcomes depending on the patient's race and ethnicity. Advanced stages can be tackled by novel targeted therapies and immunotherapy. We aimed to investigate the real‐world data in Latino‐Hispanic patients diagnosed with Stage III melanoma residing in Peru, a region marked by limited resources and healthcare infrastructure.
Methods
Patients diagnosed with Stage III melanoma at the Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru were included from the years 2010 to 2020. Cox regression analysis was used to assess prognostic factors.
Results
Four hundred twelve patients were included, the median age of diagnosis was 63 years, with a male predominance (55.6%). Most of the patients presented with a lesion in the lower extremities (77.4%), acral lentiginous melanoma (35.4%), and ulcerated tumors (72.3%). 64.1% were diagnosed with Stage IIIC, and 27.2% received interferon‐alpha therapy. With a median follow‐up of 36 months, the relapse‐free survival and overall survival rates were 26% and 78% at 3 years follow‐up, respectively. Prognostic factors of event‐free survival (EFS) were greater age (HR = 1.015, 95% CI: 1.005–1.025), ulcerated lesions (HR = 1.855, 95% CI: 1.221–2.820), N category, and the administration of interferon therapy (HR = 0.680, 95% CI: 0.488–0.947). While worse overall survival (OS) was associated with greater ages (HR = 1.032, 95% CI: 1.011–1.053) and the presence of ulceration (HR = 2.992, 95% CI:1.142–7.835).
Conclusion
Stage III melanoma in the Hispanic‐Latino population from Peru has worse survival rates than other races and populations despite similar prognostic factors of worse EFS and OS. In resource‐limited settings, reducing barriers to receiving healthcare and broadening access to contemporary immunotherapy and targeted therapy are crucial measures to improve outcomes in patients with advanced melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Universidad Cientifica del Sur, Lima, Peru.
- University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- DeWitt Daughtry Family Department of Surgery, Division of Plastic Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
- Department of Surgery, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
- Department of Plastic Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Plastic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Gabriel De La Cruz Ku, Gonzalo Ziegler-Rodriguez
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
De La Cruz Ku, G., Guart, J. A., Farzan, J. J., Desai, A., Franco, C., Mroueh, J., Mroueh, V., & Ziegler-Rodriguez, G. (2025). Real World Data in Stage III Melanoma in Latino Low Middle Income Country: Prognostic Factors and Outcomes. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28047
Vancouver
De La Cruz Ku G, Guart JA, Farzan JJ, Desai A, Franco C, Mroueh J, et al. Real World Data in Stage III Melanoma in Latino Low Middle Income Country: Prognostic Factors and Outcomes. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28047
BibTeX
@article{DeLaCruzKu2025,
author = {De La Cruz Ku, Gabriel and Guart, Jiddu Antonio and Farzan, Jessica J and Desai, Anshumi and Franco, Camila and Mroueh, Jessica and Mroueh, Vanessa and Ziegler-Rodriguez, Gonzalo},
title = {Real World Data in Stage III Melanoma in Latino Low Middle Income Country: Prognostic Factors and Outcomes},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.28047}
}
EUVIMED